|
ES2542989T3
(es)
|
2005-10-12 |
2015-08-13 |
Idera Pharmaceuticals, Inc. |
Compuestos oligonucleótidos inmuno reguladores (IRO) para modular la respuesta inmune basada en receptor semejante a Toll
|
|
EP2136829A4
(en)
*
|
2007-03-16 |
2012-07-18 |
Univ Florida |
KINASE PROTEIN BINDING INHIBITORS
|
|
KR20110071108A
(ko)
*
|
2008-10-06 |
2011-06-28 |
이데라 파마슈티칼즈, 인코포레이티드 |
고콜레스테롤혈증 및 고지혈증 및 이에 관련된 질병의 예방 및 치료에서 톨-유사 수용체의 저해제의 용도
|
|
RU2015151857A
(ru)
|
2008-12-02 |
2019-01-15 |
Уэйв Лайф Сайенсес Джапан, Инк. |
Способ синтеза модифицированных по атому фосфора нуклеиновых кислот
|
|
US20100233270A1
(en)
|
2009-01-08 |
2010-09-16 |
Northwestern University |
Delivery of Oligonucleotide-Functionalized Nanoparticles
|
|
BRPI1008063A2
(pt)
*
|
2009-01-30 |
2015-08-25 |
Idera Pharmaceuticals Inc |
Agonistas sinteticas de tlr9
|
|
MX2011010050A
(es)
|
2009-03-25 |
2011-12-14 |
Univ Texas |
Composiciones para estimulación de resistencia inmune innata de mamiferos a patógenos.
|
|
MX342945B
(es)
|
2009-07-06 |
2016-10-18 |
Ontorii Inc * |
Profármacos de ácido nucleico novedosos y métodos de uso de los mismos.
|
|
EP2451974A2
(en)
*
|
2009-07-08 |
2012-05-16 |
Idera Pharmaceuticals, Inc. |
Oligonucleotide-based compounds as inhibitors of toll-like receptors
|
|
WO2011009015A1
(en)
*
|
2009-07-16 |
2011-01-20 |
Mallinckrodt Inc. |
(+) - morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
|
|
US10363251B2
(en)
|
2009-07-16 |
2019-07-30 |
Mallinckrodt Llc |
(+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
|
|
HRP20150566T1
(hr)
*
|
2009-08-27 |
2015-07-17 |
Idera Pharmaceuticals, Inc. |
Kompozicija za inhibiciju ekspresije gena i njegova upotreba
|
|
US9415046B2
(en)
|
2009-09-29 |
2016-08-16 |
Yale University |
Compositions and methods for inhibiting inflammation from and rejection of biomaterials and other methods
|
|
JP2011084517A
(ja)
*
|
2009-10-15 |
2011-04-28 |
Koreaki Taniguchi |
核酸により活性化される自然免疫応答の抑制剤及びスクリーニング方法
|
|
WO2011117353A1
(en)
*
|
2010-03-24 |
2011-09-29 |
Mirrx Therapeutics A/S |
Bivalent antisense oligonucleotides
|
|
EP2593095B1
(en)
|
2010-07-16 |
2019-03-27 |
Mallinckrodt LLC |
(+)-morphinans as antagonists of toll-like receptor 9 and therapeutic uses thereof
|
|
GB201014026D0
(en)
*
|
2010-08-20 |
2010-10-06 |
Ucl Business Plc |
Treatment
|
|
JP5686814B2
(ja)
|
2010-09-17 |
2015-03-18 |
独立行政法人科学技術振興機構 |
Ｈｍｇｂタンパクによって仲介される免疫応答の活性化の抑制剤及びスクリーニング方法
|
|
US10428019B2
(en)
|
2010-09-24 |
2019-10-01 |
Wave Life Sciences Ltd. |
Chiral auxiliaries
|
|
US8486908B2
(en)
|
2010-11-19 |
2013-07-16 |
Idera Pharmaceuticals, Inc. |
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
|
|
GB201022049D0
(en)
*
|
2010-12-29 |
2011-02-02 |
Imp Innovations Ltd |
Methods
|
|
US8877722B2
(en)
*
|
2011-03-25 |
2014-11-04 |
Idera Pharmaceuticals, Inc. |
Compositions for inhibiting gene expression and uses thereof
|
|
WO2013106068A2
(en)
*
|
2011-05-16 |
2013-07-18 |
Haus Bioceuticals, Inc. |
Therapeutic compositions of specified herbal formulations and uses thereof
|
|
EP3248982A1
(en)
|
2011-07-19 |
2017-11-29 |
Wave Life Sciences Ltd. |
Thiosulfonate reagents for the synthesis of functionalized nucleic acids
|
|
EP3533873A1
(en)
|
2011-09-14 |
2019-09-04 |
Translate Bio MA, Inc. |
Multimeric oligonucleotide compounds
|
|
CA2879066C
(en)
*
|
2012-07-13 |
2019-08-13 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant
|
|
CA2879023C
(en)
|
2012-07-13 |
2017-03-28 |
Wave Life Sciences Japan |
Asymmetric auxiliary group
|
|
CN104661664B
(zh)
|
2012-07-13 |
2020-07-03 |
波涛生命科学有限公司 |
手性控制
|
|
WO2014043544A1
(en)
*
|
2012-09-14 |
2014-03-20 |
Rana Therapeutics, Inc. |
Multimeric oligonucleotide compounds
|
|
CN103845731B
(zh)
*
|
2012-12-05 |
2015-12-02 |
复旦大学 |
抗st2/il-1r4抗体在制备防治瘙痒药物中的应用
|
|
CN103845730B
(zh)
*
|
2012-12-05 |
2015-12-09 |
复旦大学 |
抗st2/il-1 r4抗体在制备镇痛药物中的用途
|
|
WO2014110081A1
(en)
*
|
2013-01-08 |
2014-07-17 |
Idera Pharmaceuticals, Inc. |
Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
|
|
KR20140099828A
(ko)
*
|
2013-02-05 |
2014-08-13 |
닛토덴코 가부시키가이샤 |
점막 투여용 백신 조성물
|
|
GB2514591A
(en)
*
|
2013-05-30 |
2014-12-03 |
Mologen Ag |
Predictive biomarker for cancer therapy
|
|
US10322173B2
(en)
|
2014-01-15 |
2019-06-18 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
|
|
JPWO2015108048A1
(ja)
|
2014-01-15 |
2017-03-23 |
株式会社新日本科学 |
抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
|
|
US10144933B2
(en)
|
2014-01-15 |
2018-12-04 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator
|
|
MX2016009290A
(es)
|
2014-01-16 |
2017-02-28 |
Wave Life Sciences Ltd |
Diseño quiral.
|
|
US10434064B2
(en)
|
2014-06-04 |
2019-10-08 |
Exicure, Inc. |
Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications
|
|
WO2016044839A2
(en)
|
2014-09-19 |
2016-03-24 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
|
|
CA2968531A1
(en)
|
2014-11-21 |
2016-05-26 |
Northwestern University |
The sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
|
|
SK500652015A3
(sk)
|
2015-10-15 |
2017-05-03 |
Ústav Polymérov Sav |
Spôsob úpravy funkčného stavu ľubovoľnej mRNA umožňujúci jej selektívne a špecifické rozpoznanie
|
|
CN105597079A
(zh)
*
|
2016-01-11 |
2016-05-25 |
中国人民解放军第三军医大学第一附属医院 |
用于治疗银屑病的药物
|
|
CN105541947A
(zh)
*
|
2016-01-11 |
2016-05-04 |
中国人民解放军第三军医大学第一附属医院 |
拮抗tlr7/8及tlr9活化的药物分子及用途
|
|
EP3468605A4
(en)
|
2016-06-08 |
2020-01-08 |
President and Fellows of Harvard College |
MANIPULATED VIRAL VECTOR TO REDUCE INDUCTION OF IGNITION AND IMMUNE REACTIONS
|
|
WO2018039629A2
(en)
|
2016-08-25 |
2018-03-01 |
Northwestern University |
Micellar spherical nucleic acids from thermoresponsive, traceless templates
|
|
US11370794B2
(en)
|
2016-11-11 |
2022-06-28 |
Dynavax Technologies Corporation |
Toll-like receptor antagonist compounds and methods of use
|
|
AU2017364964B2
(en)
|
2016-11-23 |
2023-04-20 |
Berlin Cures GmbH |
Aptamers for use in inhibition and/or suppression of TLR9 activation
|
|
WO2018209270A1
(en)
|
2017-05-11 |
2018-11-15 |
Northwestern University |
Adoptive cell therapy using spherical nucleic acids (snas)
|
|
US11473145B2
(en)
|
2017-07-27 |
2022-10-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for determining whether a patient suffering from rhabdomyolysis achieves a response with a TLR9 antagonist
|
|
JP2021502381A
(ja)
|
2017-11-08 |
2021-01-28 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
ウイルスベクター誘発性炎症反応を阻害するための組成物および方法
|
|
ES3001123T3
(es)
*
|
2018-05-25 |
2025-03-04 |
Primmune Therapeutics Inc |
Agonistas de TLR7
|
|
KR20220150879A
(ko)
|
2019-11-26 |
2022-11-11 |
프리뮨 테라퓨틱스, 인크. |
Tlr7 효능제
|
|
KR20220125218A
(ko)
*
|
2020-01-10 |
2022-09-14 |
에스비아이 바이오테크 가부시키가이샤 |
신규한 tlr9 작용제
|